Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on: December 20,2023

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on:December 20,2023

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on: December 25,2023

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on:December 25,2023

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on: January 04,2024

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on:January 04,2024

Metabolic adaptation ensures survival of colon cancer cells

byGerman Cancer Research CenterCredit: CC0 Public DomainColon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to

Updated on: December 22,2023

Metabolic adaptation ensures survival of colon cancer cells

byGerman Cancer Research CenterCredit: CC0 Public DomainColon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to

Updated on:December 22,2023

Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure

February 2024Lara C. Pullen, PhDNew research reveals that patients with thrombocytopenia, thrombosis, and very high D-dimer levels could have platelet-activating vaccine-induced immune thrombocytopeni

Updated on: February 18,2024

Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure

February 2024Lara C. Pullen, PhDNew research reveals that patients with thrombocytopenia, thrombosis, and very high D-dimer levels could have platelet-activating vaccine-induced immune thrombocytopeni

Updated on:February 18,2024

Top medical groups, hospitals urge better access to lung cancer screening

by Cara MurezScreening tests routinely catch cases of breast and colon cancer early, but a screening test for lung cancer is sorely underused in high-risk people and that needs to change, more than 50

Updated on: December 20,2023

Top medical groups, hospitals urge better access to lung cancer screening

by Cara MurezScreening tests routinely catch cases of breast and colon cancer early, but a screening test for lung cancer is sorely underused in high-risk people and that needs to change, more than 50

Updated on:December 20,2023

Structural insights reveal how SPOP protein contributes to cancer

bySt. Jude Children's Research HospitalL to R: L to R: Brian O’Flynn, Ph.D., Matthew Cuneo, Ph.D., and Tanja Mittag, Ph.D. Credit: St. Jude Children's Research HospitalSPOP is the most m

Updated on: December 26,2023

Structural insights reveal how SPOP protein contributes to cancer

bySt. Jude Children's Research HospitalL to R: L to R: Brian O’Flynn, Ph.D., Matthew Cuneo, Ph.D., and Tanja Mittag, Ph.D. Credit: St. Jude Children's Research HospitalSPOP is the most m

Updated on:December 26,2023

'Masked' cancer drug sneaks through body to deliver anti-tumor treatment with fewer side effects

by University of ChicagoCredit: CC0 Public DomainMany cancer treatments are notoriously savage on the body; they attack healthy cells at the same time as tumor cells, causing a plethora of side e

Updated on: March 30,2024

'Masked' cancer drug sneaks through body to deliver anti-tumor treatment with fewer side effects

by University of ChicagoCredit: CC0 Public DomainMany cancer treatments are notoriously savage on the body; they attack healthy cells at the same time as tumor cells, causing a plethora of side e

Updated on:March 30,2024

Unveiling the non-canonical functions of EZH2 in prostate cancer

by Impact Journals LLCProstate cancer cells. Credit: NIH Image GalleryA new editorial paper was published inOncotargettitled "Unveiling the non-canonical functions of EZH2 in prostate

Updated on: December 26,2023

Unveiling the non-canonical functions of EZH2 in prostate cancer

by Impact Journals LLCProstate cancer cells. Credit: NIH Image GalleryA new editorial paper was published inOncotargettitled "Unveiling the non-canonical functions of EZH2 in prostate

Updated on:December 26,2023

Obstacles for breast cancer prevention in high-risk Black women

by Misti Crane,The Ohio State UniversityCredit: Unsplash/CC0 Public DomainBlack women at high risk of breast cancer face a variety of obstacles that may keep them from care that could prevent ca

Updated on: December 22,2023

Obstacles for breast cancer prevention in high-risk Black women

by Misti Crane,The Ohio State UniversityCredit: Unsplash/CC0 Public DomainBlack women at high risk of breast cancer face a variety of obstacles that may keep them from care that could prevent ca

Updated on:December 22,2023

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim

Updated on: December 22,2023

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim

Updated on:December 22,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on: December 18,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on:December 18,2023